FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/02/023425 [Registered on: 18/02/2020] Trial Registered Prospectively
Last Modified On: 26/06/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Management of Female Infertility - Endometrium Factor 
Scientific Title of Study
Modification(s)  
Management of Vandhyatva (Female infertility W.S.R.to Endometrium thickness)by an ayurvedic treatment protocol- A single arm open labelled clinical trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Jalpa Rupareliya 
Designation  2nd year PG scholar Department of Prasuti Tantra Evam Streeroga 
Affiliation  IPGT & RA Gujarat Ayurved University, jamnagar 
Address  IPGT & RA Gujarat Ayurved University near GG Hospital Jamnagar 5th floor department of Prasuti Tantra Evam Streeroga New building IPGT & RA GAU Jamnagar- 361008 Gujarat India

Jamnagar
GUJARAT
361008
India 
Phone  9765396906  
Fax    
Email  jalparupareliya20@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Shilpa Donga 
Designation  Associate Professor Department of Prasuti Tantra Evam Streeroga 
Affiliation  IPGT & RA Gujarat Ayurved University, jamnagar 
Address  IPGT & RA Gujarat Ayurved University near GG Hospital Jamnagar 5th floor department of Prasuti Tantra Evam Streeroga new building IPGT & RA GAU Jamnagar- 361008 Gujarat India

Jamnagar
GUJARAT
361008
India 
Phone  9825646796  
Fax    
Email  drshilpadonga@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Prof LP Dei 
Designation  HOD department of Prasuti Tantra evam streeroga 
Affiliation  IPGT & RA Gujarat Ayurved University, jamnagar 
Address  IPGT & RA Gujarat Ayurved University near GG Hospital Jamnagar 5th floor Department of Prasuti Tantra Evam Streeroga New building IPGT & RA GAU Jamnagar- 361008 Gujarat India

Jamnagar
GUJARAT
361008
India 
Phone  9228198366  
Fax    
Email  Deilaxmipriya@yahoo.com  
 
Source of Monetary or Material Support  
Institute for Post Graduate Teaching And Research in Ayurveda Gujarat Ayurved University near GG Hopsital Jamnagar 
 
Primary Sponsor  
Name  Institute for Post Graduate Teaching And Research in Ayurveda Gujarat Ayurved University 
Address  Institute for Post Graduate Teaching & Research in Ayurveda Gujarat Ayurved University near GG hospital jamnagar 361008 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Jalpa D Rupareliya  Institute for Post Graduate Teaching & Research in Ayurveda Gujarat Ayurved University  Department of Prasutitantra Evam Streeroga 5th floor new building Room no- 503
Jamnagar
GUJARAT 
9765396906

jalparupareliya20@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Institute for Post Graduate teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N972||Female infertility of uterine origin,  
 
Intervention / Comparator Agent
Modification(s)  
Type  Name  Details 
Comparator Agent  not applicable  not applicable 
Intervention  Yonipeechu and oral drug  Saubhagyanandana Ghrita Yonipeechu (for 6 days, for 1 cycle) along with Jivaniya Choorna orally for 30 days.  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  1. Female having active marital life of 1 year.
2. Female patients having primary and secondary both type of infertility with endometrial thickness of 7 mm diagnosed by TVS, irrespective of its cause.
4. Female patients indicated for Yogabasti and Uttarabasti.
 
 
ExclusionCriteria 
Details  1. Female patients having age less than 20 years and more than 40 years.
2. Female patients having infertility due to bilateral tubal blockage.
3. Carcinoma of reproductive tract.
4. Active inflammatory disease, eg. -Acute PID, STD like HIV, VDRL, HBsAG, HCV.
5. Congenital anomaly of reproductive tract.
6. Uncontrolled systemic disease like Diabetes, Hypertension.
7. Female patients contraindicatedfor Yogabasti and Uttarabasti.
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome
Modification(s)  
Outcome  TimePoints 
To evaluate effect of Yonipeechu and oral drug in the management of Vandhyatva (female infertility) w.s.r.to endometrium thickness.  30 days 
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
To evaluate efficacy of Yonipeechu and oral drug in the associate complains of menstrual abnormalities, like oligomenorrhoea, dysmenorrhoea, etc.  30 days 
 
Target Sample Size
Modification(s)  
Total Sample Size="10"
Sample Size from India="10" 
Final Enrollment numbers achieved (Total)= "0"
Final Enrollment numbers achieved (India)="15" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   21/02/2020 
Date of Study Completion (India) 03/04/2021 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details
Modification(s)  
No 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary
Modification(s)  
Purpose of Study 
Endometrium plays a major role in establishing a pregnancy and any alteration in this, could be a potential cause for failure of implantation thus affecting fertility. Endometrial factor is an important subset in infertility among women, Other treatments like, In-Vitro Fertilization (IVF) - Embryo Transfer (ET), Gamete Intra Fallopian Transfer (GIFT) etc are also available. But all these treatments require a healthy endometrium which is capable of implantation of embryo in mother’s womb.It is becoming clear that overcoming the current bottleneck in improvements to assisted reproductive techniques will require a closer look at the interface between uterus and embryo. Indeed, embryo implantation requires a cross talk with a receptive endometrium.Extended oestrogen treatment and adjuvant therapy, such as low dose aspirin, vaginal Sildenafil etc. are used in modern science for improving endometrium thickness but there isn’t any proved incidence for this treatment.There are many drawbacks in available modern treatment protocols, like unsatisfactory results, highly expensive and lots of side effects, frequent abortion, multiple gestations and major long term possibility of endometrial cancer.So, there is a great scope of research to find out safe, potent, less costly and effective remedies from Ayurveda classics for the management of Vandhyatva w.s.r. to Endometrial thickness. Here an effort in this direction has been put forward by this research work.
Hypothesis of Study :
Null Hypothesis: (H0): Saubhagyanandana Ghrita Yonipeechu and Jeevaniya Churna orally is not effective in the management of Vandhyatva (female infertility) w.s.r to endometrium thickness?

Alternative Hypothesis (H1) :Saubhagyanandana Ghrita Yonipeechu and Jeevaniya Churna orally is effective in the management of Vandhyatva (female infertility) w.s.r to endometrium thickness?

Plan of study: 
(1)                Review of Literature
(2)                Pharmacognostical study
(3)                Pharmaceutical study
(4)                Clinical study
Clinical study
DIAGNOSTIC CRITERIA: Female patients having endometrial thickness 
£ 7 mm on TVS findings (up to 14th day of menstrual cycle) will be included for the study.
INCLUSION CRITERIA:
1.      Females of child bearing age of 20 to 40 years.
2.      Female having active marital life of 1 year.
3.      Female patients having primary and secondary both type of infertility with endometrial thickness£ 7 mm diagnosed by TVS, irrespective of its cause.
EXCLUSION CRITERIA:
1.      Female patients having age less than 20 years and more than 40 years.
2.      Female patients having infertility due to bilateral tubal blockage.
3.      Carcinoma of reproductive tract.
4.      Active inflammatory disease, eg. -Acute PID, STD like HIV, VDRL, HBsAG, HCV.
5.      Congenital anomaly of reproductive tract.
6.      Uncontrolled systemic disease like Diabetes, Hypertension.
Investigations:
1. General investigations
         Hematological Examination- Hb% , T.L.C., D.L.C., E.S.R.,PCV [BT,AT]
         Biochemical Examination: FBS. [BT,AT]
         Urine Examination: Routine and Microscopic examination. [BT,AT]
         Serological Examination- HIV, HBsAg, VDRL, HCV[BT]
         Pregnancy test – if required.
2.   Special Investigation:
Transvaginal Ultrasonography (B.T,  A.T.) - To see the Appel Baums Uterine Scoring Pattern.

TREATMENT PROTOCOL:
Enrolled patients fulfilling the criteria will be given following treatment.

DRUG

DOSE

ROUTE

DURATION

Saubhagyanandana Ghrita

3-5ml once daily for 6 days

Intravaginal

1 cycle

Jeevaniya Churna

6 gm BD

Orally with Anupana of Milk

30 days

PATHYA-APATHYA
Pathya (do) and Apathya (don’ts) will be advised to the patients as per Prakriti, Kala etc.
 
WITHDRAWAL CRITERIA
Patient will be withdrawal from the study if any serious complication developed which requires urgent treatment during the study.
 
FOLLOW UP
After the completion of treatment, follow up study will be done for 1 month with the interval of 15 days.
CRITERIA OF ASSESSMENT:

SUBJECTIVE PARAMETER:  Subjective Parameter will be assessed where effect will be seen on the basis of changes at end point in comparison to base line score.It includes following parameters:

 

Before treatment

After treatment

Follow Up

Regularity

Regular/Irregular

Regular/Irregular

 

Regular/Irregular

 

Quantity

Scanty/Moderate/

Excessive

 

Scanty/Moderate/

Excessive

 

Scanty/Moderate/

Excessive

 

Duration

 

 

 

Interval

 

 

 

Painful/painless:

 

 

 

Character of flow

clots/watery/ foul smelling

clots/watery/ foul smelling

clots/watery/ foul smelling

 
 
2. OBJECTIVE PARAMETER: The assessment will be done on the basis of the Appelbaum’s Uterine Scoring System for Reproduction ("USSR") by Trans Vaginal Sonography by color Doppler. It includes following parameters:
  1. Endometrial Thickness (mm)
  2. Endometrial layering
  3. Myometrial Echogenicity
  4. Uterine artery Doppler flow (PI)
  5. Endometrial blood flow in zone 3
  6. Myometrial blood flow (Gray scale)


 
 
Close